Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17395241 | 0.90 | KMT2A (0.40) | ALDH1A1KMT2APOLBTLR8AGTR1 | |
| SCHEMBL17395232 | 0.83 | ALDH1A1 (0.34) | ALDH1A1KMT2APOLBTLR8AGTR1 | |
| SCHEMBL893369 | 0.80 | ALDH1A1 (0.59) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL1829325 | 0.77 | ALDH1A1 (0.53) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL3171422 | 0.76 | ALDH1A1 (0.51) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL10352847 | 0.76 | TLR8 (0.61) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL5657514 | 0.75 | ALDH1A1 (0.58) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL11050657 | 0.74 | ALDH1A1 (0.57) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL28837797 | 0.73 | TLR8 (0.57) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL114012 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164527-A1 | SYNTHESIS AND USE OF BIO-BASED IMIDAZOLIUM CARBOXYLATES | Université de Bourgogne (FR) | 2017-05-10 | — | — | EP | disclosed |
| WO-2016001436-A1 | SYNTHESIS AND USE OF BIO-BASED IMIDAZOLIUM CARBOXYLATES | Université de Bourgogne (FR) | 2016-01-07 | — | — | WO | disclosed |
| US-7767852-B2 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-7351339-B2 | Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-01 | — | — | US | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| EP-0181078-B2 | Process for the preparation of formic acid | BP CHEM INT LTD (GB) | 1994-09-14 | — | — | EP | disclosed |
| EP-0181078-B1 | PROCESS FOR THE PREPARATION OF FORMIC ACID | BP Chemicals Limited (GB) | 1989-10-18 | — | — | EP | disclosed |
| US-4855496-A | Process for the preparation of formic acid | BP CHEMICALS LIMITED (GB) | 1989-08-08 | — | — | US | disclosed |
| EP-0181078-A1 | Process for the preparation of formic acid | BP Chemicals Limited (GB) | 1986-05-14 | — | — | EP | disclosed |
| WO-1986002066-A1 | PROCESS FOR THE PREPARATION OF FORMIC ACID | BP CHEMICALS LIMITED (GB) | 1986-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | ALDH1A1 4228/4885KMT2A 1005/4885POLB 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.